Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Monday released topline results from its randomized controlled clinical study (VP-VLY-686-2601) evaluating tradipitant to prevent nausea and vomiting induced by Wegovy.VNDA is surging to new heights today. See the full breakdown hereThe trial studied 116 healthy overweight or obese adults.Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide) is a GLP-1 receptor agonist for overweight and obese adults.GLP-1 drugs are associated with early discontinuations due to gastro ...